Clinical Study to Evaluate the Possible Efficacy and Safety of Mebendazole in Patients With Ulcerative Colitis Treated With Mesalamine
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
To evaluate the possible efficacy and safety of mebendazole in patients with ulcerative colitis treated with mesalamine
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:
• Age ≥ 18 years old Both male and female will be included Mild and moderate UC patients diagnosed and confirmed by endoscope Patient treated with 5-aminosalislic acid (mesalamine)
Locations
Other Locations
Egypt
Tanta Unuversity
RECRUITING
Tanta
Time Frame
Start Date: 2024-04-20
Estimated Completion Date: 2026-05
Participants
Target number of participants: 46
Treatments
No_intervention: Control Group
control group (Mesalamine group, n =23) who will receive 1 g mesalamine three times daily for 6 months.
Active_comparator: Treatment Group
Treatment group( mebendazole group, n = 23) which will receive the standard treatment for UC plus mebendazole 500 mg twice daily for 6 months
Related Therapeutic Areas
Sponsors
Leads: Tanta University